NCCN Continuing Education |

Title	Credit	Cost	Dates
NCCN Pharmacy Updates: Updates in the Treatment of Adult Acute Lymphoblastic Leukemia	1.00 ANCC contact hours 1.00 ANCC Pharmacology Contact Hours 1.00 AMA PRA Category 1 Credit™ 1.00 ACPE contact hours 1.00 AAPA Category 1 CME credit 1.00 Participation	$0.00	12/20/2023 - 12:30pm to 1:30pm EST
NCCN Pharmacy Updates: Advances in Targeted Therapy for Biliary Tract Cancers	1.00 ANCC contact hours 1.00 ANCC Pharmacology Contact Hours 1.00 AMA PRA Category 1 Credit™ 1.00 ACPE contact hours 1.00 AAPA Category 1 CME credit 1.00 Participation	$0.00	12/14/2023 - 1:00pm to 2:00pm EST

Title	Credit	Type	Cost
Unlocking the Potential of Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: The Role of Checkpoint Inhibitors	1.75 ANCC contact hours 1.75 AMA PRA Category 1 Credit™ 1.75 AAPA Category 1 CME credit 1.75 Participation	Enduring	$0.00
The Evolving Landscape in CLL/SLL: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations	1.75 ANCC contact hours 1.75 AMA PRA Category 1 Credit™ 1.75 ACPE contact hours 1.75 AAPA Category 1 CME credit 1.75 Participation	Enduring	$0.00
Managing Pain in Cancer Survivors	0.25 ANCC contact hours 0.25 AMA PRA Category 1 Credit™ 0.25 ACPE contact hours 0.25 AAPA Category 1 CME credit 0.25 Participation	Enduring	$0.00
Evidence-Based Guidance on New Paradigms in the Treatment of Acute Myeloid Leukemia	1.00 ANCC contact hours 1.00 AMA PRA Category 1 Credit™ 1.00 ACPE contact hours 1.00 AAPA Category 1 CME credit 1.00 Participation	Enduring	$0.00
Diagnosis and Management of Breast Cancer: What does the Evidence Show, What are We Doing, And What’s on the Horizon?	0.75 ANCC contact hours 0.75 AMA PRA Category 1 Credit™ 0.75 AAPA Category 1 CME credit 0.75 Participation	Enduring	$0.00

NCCN Continuing Education